Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment
Open Access
- 1 February 2017
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 31 (2), 194-207
- https://doi.org/10.1016/j.ccell.2017.01.004
Abstract
No abstract availableFunding Information
- NIH (PO1 CA165997, RO1 CA092900, T32 CA009140)
This publication has 55 references indexed in Scilit:
- Type I interferons in anticancer immunityNature Reviews Immunology, 2015
- Microenvironmental regulation of tumor progression and metastasisNature Medicine, 2013
- Hope and Fear for Interferon: The Receptor-Centric Outlook on the Future of Interferon TherapyJournal of Interferon & Cytokine Research, 2013
- Vascular endothelial growth factor–induced elimination of the type 1 interferon receptor is required for efficient angiogenesisBlood, 2011
- Effects of IFN‐α as a signal‐3 cytokine on human naïve and antigen‐experienced CD8+ T cellsEuropean Journal of Immunology, 2010
- Virus-Induced Unfolded Protein Response Attenuates Antiviral Defenses via Phosphorylation-Dependent Degradation of the Type I Interferon ReceptorCell Host & Microbe, 2009
- Mechanisms of type-I- and type-II-interferon-mediated signallingNature Reviews Immunology, 2005
- Links between innate and adaptive immunity via type I interferonCurrent Opinion in Immunology, 2002
- IFN-α-Expressing Tumor Cells Enhance Generation and Promote Survival of Tumor-Specific CTLsThe Journal of Immunology, 2000
- CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.1998